Treating Troubling Tumors: CAR T Therapy For Aggressive Childhood T Cell Leukemia
CAR T therapy has yet to be translated for T cell derived leukemias. One study leaves room for hope, as their CAR T product demonstrates early proof-of-concept.
Related Articles
7 Pillars for Transforming Mental Health and Substance Abuse Care in the United States
As of February 2023, more than 30% of adults report symptoms of depression and/or anxiety.
Strategic Partnership Between IonQ And QuantumBasel Could Transform Switzerland Into A European Quantum Powerhouse
Vice President of AI & Quantum Computing, Paul Smith-Goodson dive into the strategic partnership between IoQ and QuantumBasel.
Healthcare Cybersecurity Specialists Will Face Unprecedented Demand In The Coming Years
With increasing threats to healthcare organizations, the field of cybersecurity has never been more important.
Council Post: Unleashing The Retro Charm: How To Leverage Traditional Marketing To Thrive In The Digital Age
In an era dominated by social media, influencers and viral videos, it’s easy to assume that traditional marketing methods have been left in the dust.
Value-Based Healthcare Battle: Kaiser-Geisinger Vs. Amazon, CVS, Walmart
Hospital superpowers face intensifying pressure from retailers like Amazon, CVS and Walmart.
England To Miss Major Milestone In âAilingâ Hospital Building Project
“The programme has come after a lost decade of investment in hospital buildings in England,” one expert said.
The Next Frontier For Large Language Models Is Biology
A whole new category of generative AI is emerging as LLMs learn the language of life.
The Next Frontier For Large Language Models Is Biology
A whole new category of generative AI is emerging as LLMs learn the language of life.
Amputated Feet, Mangled âManhoodâ And Which Body Part Will Be Next
Lives ruined by questionable artery clearing surgery and penis enlargement surgery both are connected to one controversial FDA rule.
Seeing The Future: Artificial Intelligence For Age-Related Macular Degeneration
Identifying those at risk of age-related macular degeneration is challenging but new technologies like artificial intelligence pave the way for more accurate diagnosis.